In patients with ulcerative colitis exposed to anti-TNF therapy, tofacitinib is linked to higher rates of clinical and ...

Merck & Co Inc. MRK on Monday said its investigational therapy tulisokibart achieved the primary endpoint in a Phase 3 study ...

Hyperbaric oxygen therapy was well tolerated in treatment-refractory ulcerative colitis and enhanced clinical outcomes alongside improved bowel perfusion.

Merck MRK announced positive results from Study 2 of the late-stage ATLAS-UC study, which evaluated tulisokibart, its ...

Amebic Colitis is caused by the anaerobic parasitic amoebozoan Entameba histolytica. This bacterium infects the mucosa in the colon and accounts for 100,000 deaths annually. The parasite infects 10% ...

COLUMBUS, Ohio (WCMH) — Hundreds of families are expected to take part in Take Steps Central Ohio at Coffman Park in Dublin ...

Merck & Co. said a late-stage study of its autoimmune drug candidate tulisokibart in ulcerative colitis hit its key goals. Merck on Monday said the Phase 3 induction-only study met its primary ...

ABIVAX Société Anonyme (NASDAQ:ABVX) is one of the best up and coming stocks to buy for the next 3 years. On June 1, Abivax ...

Our gut is the key to much of our body's overall health, which is why diseases like ulcerative colitis can be so detrimental. Ulcerative colitis is one of the most common inflammatory bowel diseases.

Ulcerative colitis is a chronic condition that affects the large intestines, particularly the colon. It is classified as one of the two inflammatory bowel diseases along with Crohn’s disease. The ...

Hundreds of people gathered at the Grant Pavilion at Millennium Park in Walker on Saturday to show support for those ...

Exposure tied to modest increased risk of IBD, but with very low absolute risk ...